(Q73850585)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837779%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Pharmacokinetic/pharmacodynamic modeling of antitumor agents encapsulated into liposomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837779%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

1 reference

Harashima H

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837779%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Tsuchihashi M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837779%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Iida S

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837779%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Doi H

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837779%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Kiwada H

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837779%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837779%20AND%20SRC:MED&resulttype=core&format=json

Advanced Drug Delivery Reviews

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837779%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837779%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837779%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

39-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837779%20AND%20SRC:MED&resulttype=core&format=json

Sterically stabilized liposomes

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Pharmacodynamics of Chemotherapeutic Effects: Dose-Time-Response Relationships for Phase-Nonspecific Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration--time product.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Residence time distributions of various tracers in tumors: implications for drug delivery and blood flow measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Clinical pharmacokinetics-pharmacodynamics of anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

A pharmacokinetic analysis program (multi) for microcomputer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

A nonlinear least squares program based on differential equations, MULTI (RUNGE), for microcomputers.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Comparison of free and liposome encapsulated doxorubicin tumor drug uptake and antitumor efficacy in the SC115 murine mammary tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Kinetic analysis of AUC-dependent saturable clearance of liposomes: mathematical description of AUC dependency.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Evaluation of the efficiency of targeting of antitumor drugs: simulation analysis based on pharmacokinetic/pharmacodynamic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Dependence of the cytostatic effect of adriamycin on drug concentration and exposure time in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Doxorubicin weekly low dose administration: in vitro cytotoxicity generated by the typical pharmacokinetic profile

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Pharmacokinetic analysis of drug disposition after intratumoral injection in a tissue-isolated tumor perfusion system.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Endocytosis does not necessarily augment the cytotoxicity of adriamycin encapsulated in immunoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

A clinicopathologic analysis of adriamycin cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Doxorubicin: effect of different schedules on toxicity and anti-tumor efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Kinetic analysis of tissue distribution of doxorubicin incorporated in liposomes in rats (II).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Free and liposomal doxorubicin treatment of intraperitoneal colon 26 tumor: therapeutic and pharmacologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Development of anti-p185HER2 immunoliposomes for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

Species difference in the disposition of liposomes among mice, rats, and rabbits: allometric relationship and species dependent hepatic uptake mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900039-3

7 January 2021

10.1016/S0169-409X(99)00039-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837779%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference